An approvable letter is sent by the FDA when a drugmaker's New Drug Application is not sufficient for approval, but has the potential to be approved at a later date. The letter spells out what problems the FDA had with the marketing application. Often times further meetings with the FDA are required to determine what needs to be done to get the drug approved.
Recent Mentions on Fool.com
- Why Pacira Pharmaceuticals Inc. Stock Cratered
- 4 Priceless Contract Negotiation Tips to Keep You in Control of the Deal
- Why Sarepta Therapeutics Inc. Shares Crashed 17% in January
- This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
- You're Not Going to Believe What Comcast Is Doing to Gain FCC Approval of Its Time Warner Merger
- 3 Small-Cap Biotech Stocks That Could Be Top Stocks in 2015